REQUEST A DEMO
Total
USD $0.00
Search more companies

Zuellig Pharma Sdn. Bhd. (Malaysia)

Main Activities: Health and Personal Care Stores
Full name: Zuellig Pharma Sdn. Bhd. Profile Updated: March 11, 2021
Buy our report for this company USD 29.95 Most recent financial data: 2019 Available in: English Download a sample report

Stores Specialized In Retail Sale Of Pharmaceuticals, Medical And Orthopaedic Goods (SSM)


In 1939, Zuellig Pharma launched its Malaysia operations by opening an office in Penang as a branch of its Singapore operations. Trading in pharmaceuticals, chemicals, agriculture and technical products, Zuellig Pharma was incorporated in 1960 in Malaysia under the name F.E. Zuellig Trading Ltd. The company's rapid growth prompted the separation of its numerous divisions into individual companies, which in turn led to the formation of Zuellig Pharma.

Since then, Zuellig Pharma has established itself as the leading distributor of pharmaceutical and healthcare products in Malaysia, distinguishing itself through its advanced IT systems and quality systems and procedures, high delivery service standards and strong relationships with principals and customers. At present, Zuellig Pharma serves over 10,000 customers throughout Malaysia, and distributes over 8,000 products for its principals.

At the heart of Zuellig Pharma's distribution network is our state-of-the-art ISO 9001:2000 certified Central Distribution Center serving six strategically located Customer Care Centers across Peninsular Malaysia and emphasizing our commitment to incorporating the most advanced technology into our services. We have two branch offices with warehouse operations in East Malaysia as well as one in Brunei, which offer a full range of distribution and sales services.

In Brunei, Zuellig Pharma has established itself as the sole multinational pharmaceutical distributor in the country.

A major investment is our 24,000-square-meter Distribution Center (DC) and office in Bukit Jelutong, which was fully operational since January 2008. Operating in a largely paperless warehousing environment via radio frequency processes, the new DC is one of the country’s most modern distribution facilities equipped with state-of-the-art warehousing technology. One advanced feature is its hi-tech automated sortation system providing improved security and greater accuracy along with real-time inventory information.

Headquarters
No 15, Level 2, Persiaran Pasak Bumi Seksyen U8 Perindustrian Bukit Jelutung 40150 Shah Alam Selangor
Shah Alam; Selangor; Postal Code: 40150

Contact Details: Purchase the Zuellig Pharma Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Zuellig Pharma Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Zuellig Pharma Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Zuellig Pharma Sdn. Bhd. report to view the information.
Ratings:
Purchase the Zuellig Pharma Sdn. Bhd. report to view the information.
Incorporation Date:
December 12, 1960
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Company Performance
Financial values in the chart are available after Zuellig Pharma Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
19.01%
Total operating revenue
19.01%
Net Profit (Loss) for the Period
59.45%
Total assets
25.66%
Total equity
-66.3%
Net Profit Margin
0.13%
Return on Equity (ROE)
178.48%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?